Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose terlipressin plus noradrenaline for severe shock with vascular hyporeactivity
ChiCTR-TRC-11001583Phase 4Completed
- Sponsor
- PLA Army Specialty Medical Center
- Start
- May 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of terlipressin and norepinephrine in Shock (3 arms), sponsored by PLA Army Specialty Medical Center. Primary endpoints: Consumption of vasoactive drugs, Liver and kidney function, blood gas analysis, and complete blood count and 2 more. Started May 2011; status: completed.
02
Drugs
terlipressinnorepinephrine
03
Conditions
Shock
Beyond the preview
Go deeper on ChiCTR-TRC-11001583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001583.